Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat

Brain Res. 2000 Jun 2;866(1-2):128-34. doi: 10.1016/s0006-8993(00)02257-5.

Abstract

The melanocortin-4 receptor (MC4-R) appears to be an important downstream mediator of the action of leptin. We examined to what extent the anorectic effects of cocaine- and amphetamine-regulated transcript (CART), glucagon-like peptide-1 (GLP-1) and corticotrophin releasing factor (CRF) might be mediated via MC4-R. alpha-Melanocyte stimulating hormone (alpha-MSH), the MC4-R agonist, administered intracerebroventricularly (ICV) at a dose of 1 nmol reduced food intake by approximately half. Agouti-related protein (Agrp) (83-132), a biologically active fragment of the endogenous MC4-R antagonist, administered ICV at a dose of 1 nmol completely blocked the anorectic effect of 1 nmol alpha-MSH. CART (55-102) (0.2 nmol), GLP-1 (3 nmol) and CRF (0.3 nmol) produced a reduction in feeding of approximately the same magnitude as 1 nmol alpha-MSH. Agrp (83-132) (1 nmol) administered ICV did not block the anorectic effects of CART (55-102) (1 h food intake, 0.2 nmol CART (55-102), 2.7+/-0.8 g vs. CART (55-102)+Agrp (83-132), 2.6+/-0.6 g, P=0.87; saline control 5.4+/-0.3 g, P<0.001 vs. both groups). Agrp (83-132) also did not block the anorectic effects of GLP-1 or CRF (1 h food intake, 0.3 nmol CRF, 0.7+/-0.3 g vs. CRF+Agrp (83-132), 0.7+/-0.3 g, P=0.91; 3 nmol GLP-1, 1.9+/-0.4 g vs. GLP-1+Agrp (83-132), 1.1+/-0. 5 g, P=0.23; saline control 5.0+/-0.6 g, P<0.001 vs. all four groups). Thus, as previous data suggests, GLP-1 and CRF do not appear to reduce food intake predominantly via MC4-R, we here demonstrate for the first time that CART, in addition to GLP-1 and CRF primarily acts via Agrp independent pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agouti-Related Protein
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Corticotropin-Releasing Hormone / metabolism*
  • Corticotropin-Releasing Hormone / pharmacology
  • Eating / drug effects*
  • Eating / physiology
  • Glucagon / metabolism*
  • Glucagon / pharmacology
  • Glucagon-Like Peptide 1
  • Intercellular Signaling Peptides and Proteins
  • Leptin / metabolism
  • Male
  • Nerve Tissue Proteins / metabolism*
  • Nerve Tissue Proteins / pharmacology
  • Peptide Fragments / metabolism*
  • Peptide Fragments / pharmacology
  • Protein Precursors / metabolism*
  • Protein Precursors / pharmacology
  • Proteins / metabolism*
  • Proteins / pharmacology
  • Rats
  • Rats, Wistar
  • Receptor, Melanocortin, Type 4
  • Receptors, Peptide / antagonists & inhibitors
  • Receptors, Peptide / drug effects*
  • Receptors, Peptide / metabolism
  • alpha-MSH / pharmacology

Substances

  • AGRP protein, rat
  • Agouti-Related Protein
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Nerve Tissue Proteins
  • Peptide Fragments
  • Protein Precursors
  • Proteins
  • Receptor, Melanocortin, Type 4
  • Receptors, Peptide
  • cocaine- and amphetamine-regulated transcript protein
  • alpha-MSH
  • Glucagon-Like Peptide 1
  • Glucagon
  • Corticotropin-Releasing Hormone